Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microchimerism: friend or foe?

A Tyndall, A Gratwohl

    Nature Medicine
    |April 18, 1998
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

    Leukemia·2017
    Same author

    Latin America: the next region for haematopoietic transplant progress.

    Bone marrow transplantation·2017
    Same author

    Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

    Leukemia·2017
    Same author

    Latin America: the next region for haematopoietic transplant progress.

    Bone marrow transplantation·2017
    Same author

    The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

    Bone marrow transplantation·2016
    Same author

    Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

    Leukemia & lymphoma·2016
    Same journal

    Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

    Nature medicine·2026
    Same journal

    Data rights are the missing pillar for modernizing consent in medicine.

    Nature medicine·2026
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    See all related articles